Department of Animal Biology and Mari Lowe Center for Comparative Oncology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
J Biol Chem. 2011 Jun 24;286(25):22069-76. doi: 10.1074/jbc.M111.238766. Epub 2011 May 3.
Phosphorylation-dependent ubiquitination and degradation of the IFNAR1 chain of type I interferon (IFN) receptor is a robust and specific mechanism that limits the magnitude and duration of IFNα/β signaling. Besides the ligand-inducible IFNAR1 degradation, the existence of an "inside-out" signaling that accelerates IFNAR1 turnover in the cells undergoing the endoplasmic reticulum (ER) stress and activated unfolded protein responses has been recently described. The latter pathway does not require either presence of ligands (IFNα/β) or catalytic activity of Janus kinases (JAK). Instead, this pathway relies on activation of the PKR-like ER kinase (PERK) and ensuing specific priming phosphorylation of IFNAR1. Here, we describe studies that identify the stress activated p38 protein kinase as an important regulator of IFNAR1 that acts downstream of PERK. Results of the experiments using pharmacologic p38 kinase inhibitors, RNA interference approach, and cells from p38α knock-out mice suggest that p38 kinase activity is required for priming phosphorylation of IFNAR1 in cells undergoing unfolded protein response. We further demonstrate an important role of p38 kinase in the ligand-independent stimulation of IFNAR1 ubiquitination and degradation and ensuing attenuation of IFNα/β signaling and anti-viral defenses. We discuss the distinct importance of p38 kinase in regulating the overall responses to type I IFN in cells that have been already exposed to IFNα/β versus those cells that are yet to encounter these cytokines.
磷酸化依赖性泛素化和降解 I 型干扰素(IFN)受体的 IFNAR1 链是一种强大而特异的机制,可限制 IFNα/β信号的幅度和持续时间。除了配体诱导的 IFNAR1 降解外,最近还描述了一种“内-外”信号,该信号可加速内质网 (ER) 应激和激活未折叠蛋白反应的细胞中 IFNAR1 的周转率。后一种途径既不需要配体(IFNα/β)的存在,也不需要 Janus 激酶(JAK)的催化活性。相反,该途径依赖于 PKR 样 ER 激酶(PERK)的激活以及随后 IFNAR1 的特异性初始磷酸化。在这里,我们描述了确定应激激活的 p38 蛋白激酶作为 IFNAR1 的重要调节剂的研究,该调节剂在 PERK 下游起作用。使用药理 p38 激酶抑制剂、RNA 干扰方法和 p38α 敲除小鼠的细胞进行的实验结果表明,p38 激酶活性是细胞中未折叠蛋白反应时 IFNAR1 初始磷酸化所必需的。我们进一步证明了 p38 激酶在配体非依赖性刺激 IFNAR1 泛素化和降解以及随后减弱 IFNα/β信号和抗病毒防御中的重要作用。我们讨论了 p38 激酶在调节已接触 IFNα/β的细胞与尚未接触这些细胞的细胞对 I 型 IFN 的整体反应中的不同重要性。